VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WORXSCWorx Corp.
$0.74$202035
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

WORX logoSCWorx Corp.(WORX)Earnings, Financials & Key Ratios

WORX•NASDAQ
$0.74
Price updated Jun 20, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryHealthcare Data, Analytics and AI
AboutSCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.Show more
  • Revenue$3M-3.7%
  • EBITDA-$958K
  • Net Income-$4M-291.1%
  • EPS (Diluted)-9.15+21.8%
  • Gross Margin31.96%+28.1%
  • EBITDA Margin-33.3%
  • Operating Margin-33.32%+20.9%
  • Net Margin-154.44%-306.3%
  • ROE-76.35%-180.3%

WORX Price & Volume

SCWorx Corp. (WORX) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Obscure Asset Valuation Risks

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Capital exhaustion and insolvency
"SCWorx faces a challenging fundamental outlook characterized by stagnant revenue growth, which fluctuated between $675.7K and $910.3K over the last ten quarters, and a persistent inability to achieve positive operating income. The company's reliance on a $5.8M goodwill balance, representing the majority of its $7.8M total assets, suggests significant impairment risk given the ongoing net losses and negative margins. Investors should remain cautious as the firm's structural cash burn and lack of a clear path to profitability necessitate a fundamental pivot to avoid further equity erosion."

Verdict Logic

the company has failed to generate positive free cash flow in any of the last ten quarters, with a trough FCF margin of -95.5% in 2025Q2, indicating severe liquidity and operational viability risks.

WORX Growth Metrics

SCWorx Corp. (WORX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-11.21%
3 Years-10.68%
TTM0.15%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-188.84%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM26.59%

Return on Capital

10 Years-112.4%
5 Years-32.62%
3 Years-24.31%
Last Year-16.44%

Peers Comparison

Key metrics vs top competitors for SCWorx Corp. (WORX)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
WORX logoWORXSCWorx Corp.Current
$0.74$202.03K-0.08-3.75%-154.44%-76.35%—
HCAT logoHCATHealth Catalyst, Inc.
$1.77$130.79M-0.691.48%-87.69%-99.78%—
VEEV logoVEEVVeeva Systems Inc.
$158.08$25.68B29.0616.34%28.37%13.36%—
DOCS logoDOCSDoximity, Inc.
$19.85$3.71B20.2613.05%30.4%19.36%—
MCK logoMCKMcKesson Corporation
$763.81$91.81B19.9012.36%1.18%——
CAH logoCAHCardinal Health, Inc.
$234.75$55.24B36.40-1.87%0.62%——

Compare WORX vs Peers

SCWorx Corp. (WORX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HCAT

Most directly comparable listed peer for WORX.

Scale Benchmark

vs MCK

Larger-name benchmark to compare WORX against a more recognizable public peer.

Peer Set

Compare Top 5

vs HCAT, VEEV, DOCS, MCK

WORX SEC Filings & Documents

SCWorx Corp. (WORX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 10, 2026·SEC

Material company update

Apr 7, 2026·SEC

Material company update

Dec 10, 2025·SEC

10-K Annual Reports

4
FY 2026

Mar 31, 2026·SEC

FY 2025

Mar 31, 2025·SEC

FY 2024

Sep 24, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 15, 2026·SEC

FY 2025

Nov 12, 2025·SEC

FY 2025

Aug 14, 2025·SEC

Get notified when WORX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

WORX Frequently Asked Questions

SCWorx Corp. (WORX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is SCWorx Corp.'s revenue?

SCWorx Corp. (WORX) reported $2.9M in revenue for fiscal year 2025. This represents a 391% increase from $0.6M in 2016.

How fast is SCWorx Corp. growing?

SCWorx Corp. (WORX) saw revenue decline by 3.7% over the past year.

Is WORX profitable?

SCWorx Corp. (WORX) reported a net loss of $4.1M for fiscal year 2025.

Dividend & Returns
What is WORX's return on equity?

SCWorx Corp. (WORX) has a return on equity (ROE) of -76.3%. Negative ROE indicates the company is unprofitable.

What is SCWorx Corp.'s free cash flow?

SCWorx Corp. (WORX) had negative free cash flow of $1.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in WORX back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →